Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
The company disclosed in its Thursday funding announcement that it’s now valued at $1.25 billion. That’s up from $250 million in November. Salesforce Ventures led the raise with participation from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results